TBL1XR1 and acute lymphoblastic leukemia: Specifically, the novel oncogenic fusions identified in Ph-like ALL patients include CENPC-ABL1, LSM14A-ABL1, NUP153-ABL1, TBL1XR1-CSF1R, ZMYND8-PDGFRB, GATAD2A-LYN, RFX3-JAK2, USP25-JAK2, and ZNF274-JAK2 [107].